Cargando…
How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncology
Technical advances in imaging are well demonstrated by MRI (Magnetic Resonance Imaging) and PET (Positron Emission Tomography). Excellent anatomical detail and a lack of ionising radiation make MRI the standard of care for most neuroimaging indications, and advanced sequences are providing an ever-g...
Autores principales: | Lasocki, Arian, Hicks, Rodney J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700829/ https://www.ncbi.nlm.nih.gov/pubmed/31426862 http://dx.doi.org/10.1186/s40644-019-0241-5 |
Ejemplares similares
-
How We Read Oncologic FDG PET/CT
por: Hofman, Michael S., et al.
Publicado: (2016) -
Beyond FDG: novel PET tracers for cancer imaging
por: Hicks, Rodney J
Publicado: (2003) -
PET tracer development—a tale of mice and men
por: Hicks, Rodney J, et al.
Publicado: (2006) -
Update on the Use of PET/MRI Contrast Agents and Tracers in Brain Oncology: A Systematic Review
por: Smeraldo, Alessio, et al.
Publicado: (2022) -
PET Tracers for Imaging Cardiac Function in Cardio-oncology
por: Kelly, James M., et al.
Publicado: (2022)